Lakewood-Amedex Biotherapeutics Inc LABT
$1.88 $0.02 (1.05%) 1D
Last Updated: Sep 04, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Lakewood-Amedex Biotherapeutics Inc Stock Halal?
Shariah Compliance Analysis of LABT Stock
United States Health Care Nano Cap No. As of September 2026, Lakewood-Amedex Biotherapeutics Inc (LABT) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Lakewood-Amedex Biotherapeutics Inc does not pass Musaffa's business and financial screening criteria.
Lakewood-Amedex Biotherapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in University Park, Florida and currently employs 5 full-time employees. The company went IPO on 2026-04-23. Lakewood-amedex Biotherapeutics Inc is a pharmaceutical company. The firm is focused on addressing unmet needs in the treatment of serious infectious diseases, improving patient outcomes, and significantly reducing the threat posed by antibiotic-resistant bacterial strains like MRSA, NDM-1, and many others. The firm is engaged in development of its Bisphosphocin class of antimicrobial agents. The firm is exploring additional local drug delivery applications, including complicated urinary tract infections (CAUTI) and pulmonary infections. The firm has a portfolio of compounds that are being profiled for indications such as infected diabetic foot ulcer, urinary tract infections, and pulmonary infections.
LABT Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Lakewood-Amedex Biotherapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Lakewood-Amedex Biotherapeutics Inc (LABT) Chart
Financial Metrics & Statements of Lakewood-Amedex Biotherapeutics Inc (LABT)
FAQ's for Lakewood-Amedex Biotherapeutics Inc (LABT)
- As of September 2026, Lakewood-Amedex Biotherapeutics Inc LABT is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Lakewood-Amedex Biotherapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Lakewood-Amedex Biotherapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Lakewood-Amedex Biotherapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Lakewood-Amedex Biotherapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Lakewood-Amedex Biotherapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Lakewood-Amedex Biotherapeutics Inc (LABT)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
